MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2026)
MAIA Biotechnology (MAIA) posted quarterly Interest Coverage Ratio of 21.12 for Q1 2026, up 8.04% year-over-year from 19.55 in Q1 2025, and down 11096.92% quarter-over-quarter from 0.19 in Q4 2025.
MAIA Biotechnology (MAIA) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
MAIA Biotechnology (MAIA) has reported Interest Coverage Ratio for 6 consecutive years, with 21.12 the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest Coverage Ratio rose 8.04% year-over-year to 21.12; the TTM figure through Mar 2026 stood at 78.4 (changed 0.45% YoY), while the FY2025 annual figure was 1.06, up 5.01% from the prior year.
- Interest Coverage Ratio declined to 21.12 in Q1 2026 per MAIA's latest filing, from 0.19 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 178735.86 in Q4 2024 and bottomed at 815.04 in Q4 2022.
- Historically, Interest Coverage Ratio has averaged 11854.86 across 5 years, with a median of 1.53 in 2024.
- Annual changes were most pronounced in 2022 — Interest Coverage Ratio surged 87.94% — and 2025, when it slumped 6138.58%.
- MAIA Biotechnology's Interest Coverage Ratio stood at 815.04 in 2022, then soared by 99.71% to 2.33 in 2023, then soared by 7682934.07% to 178735.86 in 2024, then slumped by 100.0% to 0.19 in 2025, then slumped by 11096.92% to 21.12 in 2026.
- Business Quant data shows MAIA's Interest Coverage Ratio at 21.12 in Q1 2026, 0.19 in Q4 2025, and 37.11 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | MAIA Biotechnology | 84.50 Mn | 56.91 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -16.21 |
| Mar 31, 2026 | -21.12 |
| Dec 31, 2025 | -0.19 |
| Sep 30, 2025 | -37.11 |
| Jun 30, 2025 | -8.23 |
| Mar 31, 2025 | -22.97 |
| Dec 31, 2024 | 178,735.86 |
| Sep 30, 2024 | -0.59 |
| Jun 30, 2024 | -0.33 |
| Mar 31, 2024 | -1.53 |
| Sep 30, 2023 | -2.33 |
| Jun 30, 2023 | -2.21 |
| Mar 31, 2023 | -0.47 |
| Dec 31, 2022 | -815.04 |
| Sep 30, 2022 | -0.60 |
| Jun 30, 2022 | -0.20 |
| Sep 30, 2021 | -4.95 |